Skip to content

Tag: Cardiac valvulopathy

Explore our medication guides and pharmacology articles within this category.

Why Was Fenfluramine Withdrawn? Understanding the Cardiac Dangers

4 min read
In 1997, the U.S. Food and Drug Administration (FDA) requested the withdrawal of fenfluramine from the market, a decision spurred by compelling evidence of serious cardiac risks. This critical event answers the question of **why was fenfluramine withdrawn**, fundamentally altering the landscape of weight-loss medication.